Kolexia
Schultz Philippe-Emmanuel
Oto-rhino-laryngologie
Hôpital Hautepierre
Strasbourg, France
127 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs de la tête et du cou Carcinomes Carcinome épidermoïde Carcinome épidermoïde de la tête et du cou Tumeurs du larynx Tumeurs de l'oropharynx Récidive tumorale locale Dysphonie COVID-19

Industries

Sanofi
5 collaboration(s)
Dernière en 2023
Audika Groupe SA
3 collaboration(s)
Dernière en 2023
Menarini
2 collaboration(s)
Dernière en 2023
GSK
2 collaboration(s)
Dernière en 2022

Dernières activités

Carcinomas of the external auditory canal: Management and results: A multicenter REFCOR propensity score matching study.
European journal of cancer (Oxford, England : 1990)   10 février 2024
Functional or radical surgical treatment of laryngeal chondrosarcoma, analysis of survival and prognostic factors: A REFCOR and NetSarc-ResOs multicenter study of 74 cases.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology   22 décembre 2023
Dynamic profiling of immune microenvironment during anti-PD-1 immunotherapy for head and neck squamous cell carcinoma: the IPRICE study.
BMC cancer   08 décembre 2023
A novel ΔNp63-dependent immune mechanism improves prognosis of HPV-related head and neck cancer.
Frontiers in immunology   25 octobre 2023
Management of 80 sinonasal undifferentiated carcinomas. Retrospective multicentre study of the French Network of Rare Head and Neck Cancers (REFCOR).
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology   05 octobre 2023
IPRICE: Identification of Predictive Factors for the Response to Anti-Programmed Cell Death Protein 1 (PD1) Immunotherapy in Head and Neck Squamous Cell Carcinoma
Essai Clinique (Institut de cancérologie Strasbourg Europe)   21 septembre 2023
Trattamento chirurgico delle stenosi dell’ipofaringe e della bocca dell’esofago
EMC - Tecniche Chirurgiche - Chirurgia ORL e Cervico-Facciale   01 août 2023
Tumor-Suppressive and Immunomodulating Activity of miR-30a-3p and miR-30e-3p in HNSCC Cells and Tumoroids.
International journal of molecular sciences   06 juillet 2023
Tratamiento quirúrgico de las estenosis de la hipofaringe y de la boca del esófago
EMC - Cirugía Otorrinolaringológica y Cervicofacial   01 mai 2023
Best Of: Phase III Study Assessing the "Best of" Radiotherapy Compared to the "Best of" Surgery (Trans-oral Surgery (TOS)) in Patients With T1-T2, N0-N1 Oropharyngeal, Supraglottic Carcinoma and With T1, N0 Hypopharyngeal Carcinoma
Essai Clinique (Organisation européenne pour la recherche et le traitement du cancer)   28 février 2023